| D00074 |
Nitric oxide (JAN/USAN); INOmax (TN) |
(P) unclassified |
| D00139 |
Methoxsalen (JP18/USP); Oxsoralen (TN); UVADEX (TN) |
(P) unclassified |
| D00219 |
Acetohexamide (JP18/USP/INN); Dymelor (TN) |
(P) unclassified |
| D00298 |
Digoxin (JP18/USP); Lanoxicaps (TN); Lanoxin (TN) |
(P) unclassified |
| D00336 |
Glyburide (USP); Glibenclamide (JP18/INN); Diabeta (TN); Glynase (TN); Micronase (TN) |
(P) unclassified |
| D00475 |
Probenecid (JP18/USP/INN); Benemid (TN) |
(P) unclassified |
| D00477 |
Procainamide hydrochloride (JP18/USP); Procan SR (TN); Procanbid (TN); Pronestyl (TN) |
(P) unclassified |
| D00593 |
Glimepiride (JP18/USP/INN); Amaryl (TN) |
(P) unclassified |
| D01111 |
Nateglinide (JP18/USP/INN); Starsis (TN) |
(P) unclassified |
| D01162 |
Verteporfin (JAN/USP/INN); Visudyne (TN) |
(P) unclassified |
| D01280 |
Warfarin potassium (JP18); Athrombin-K (TN) |
(P) unclassified |
| D01599 |
Gliclazide (JP18/INN); Glimicron (TN) |
(P) unclassified |
| D01799 |
Glyclopyramide (JAN/INN); Deamelin-S (TN) |
(P) unclassified |
| D01854 |
Mitiglinide calcium hydrate (JP18); Mitiglinide calcium dihydrate; Glufast (TN) |
(P) unclassified |
| D01985 |
Talaporfin sodium (JAN/USAN); Laserphyrin (TN) |
(P) unclassified |
| D02019 |
Magnesium sulfate hydrate and glucose; Magnesol (TN) |
(P) unclassified |
| D02183 |
Sodium lactate (JAN/USP); Mediject L (TN) |
(P) unclassified |
| D02587 |
Metildigoxin (JP18); Lanirapid (TN) |
(P) unclassified |
| D02740 |
Lidocaine and prilocaine; Lidocaine and propitocaine; Emla (TN); Oraqix (TN); Lidocaine and prilocaine (TN) |
(P) unclassified |
| D02908 |
Aminolevulinic acid hydrochloride (JAN/USAN); 5-Aminolevulinic acid hydrochloride; Levulan (TN); Ameluz (TN); Gleolan (TN) |
(P) unclassified |
| D03230 |
Insulin human (USP/INN); Insulin human (genetical recombination) (JP18); Insulin human (biosynthesis) (JAN); Insulin human (synthesis) (JAN); Humulin (TN) |
(P) unclassified |
| D03250 |
Insulin glargine (USAN/INN); Insulin glargine (genetical recombination) (JP18); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN); Lantus (TN) |
(P) unclassified |
| D04475 |
Insulin aspart (USP/INN); Insulin aspart (genetical recombination) (JP18); Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN); Insulin X 14; NovoRapid (TN); Novolog (TN) |
(P) unclassified |
| D04477 |
Insulin lispro (USP/INN); Insulin lispro (genetical recombination) (JAN); Insulin lispro (genetical recombination) [Insulin lispro Biosimilar 1] (JAN); Insulin lispro-aabc; Humalog (TN); Lyumjev (TN) |
(P) unclassified |
| D04539 |
Insulin detemir (USAN/INN); Insulin detemir (genetical recombination) (JAN); Levemir (TN) |
(P) unclassified |
| D04540 |
Insulin glulisine (USAN/INN); Insulin glulisine (genetical recombination) (JAN); Apidra (TN) |
(P) unclassified |
| D04547 |
Insulin, isophane (USP); Isophane insulin human (genetical recombination) injectable aqueous suspension (JP18); Isophane insulin (aqueous suspension) (JAN); Humalog PEN (TN) |
(P) unclassified |
| D05143 |
Nepafenac (JAN/USAN/INN); Nevanac (TN) |
(P) unclassified |
| D06466 |
Freeze-dried BCG for intravesical use; Immunobladder (TN); Tice BCG (TN) |
(P) unclassified |
| D08080 |
Insulin injection, biphasic isophane (BAN); Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension (JP18); Insulin Humacart (TN) |
(P) unclassified |
| D09727 |
Insulin degludec (USAN/INN); Insulin degludec (genetical recombination) (JAN); Tresiba (TN) |
(P) unclassified |
| D09848 |
Pioglitazone hydrochloride and glimepiride tablets (JP18); Pioglitazone and glimepiride; Duetact; Sonias (TN) |
(P) unclassified |
| D10160 |
Mitiglinide calcium hydrate and voglibose; Glubes (TN) |
(P) unclassified |
| D10570 |
Insulin degludec (genetical recombination) and insulin aspart (genetical recombination); Ryzodeg (TN) |
(P) unclassified |
| D10602 |
Clindamycin phosphate and benzoyl peroxide; Duac (TN); Onexton (TN) |
(P) unclassified |
| D11034 |
Insulin glargine and lixisenatide; Insulin glargine (genetical recombination) and lixisenatide; Soliqua (TN) |
(P) unclassified |
| D11567 |
Insulin degludec and liraglutide; Xultophy (TN) |
(P) unclassified |
